Targeting Obesity and Beyond
Our innovative DNA therapy leverages safe and affordable plasmids, enhanced by gBoostTM technology, to deliver targeted genetic interventions.
Our primary therapeutic focus is obesity, a major contributor to numerous age-related diseases. Unlike conventional weight loss treatments, our innovative approach targets fat reduction while preserving muscle mass – addressing a crucial aspect of metabolic health.
By tackling obesity and its related conditions, and with plans to expand into the anti-aging space, we’re striving to create a future where aging goes hand-in-hand with vitality and well-being.